Pharmacokinetic (PK) drug interaction studies of cabozantinib: Effect of CYP3A inducer rifampin and inhibitor ketoconazole on cabozantinib plasma PK and effect of cabozantinib on CYP2C8 probe substrate rosiglitazone plasma PK
Publisher: John Wiley & Sons Inc
E-ISSN: 1552-4604|55|9|1012-1023
ISSN: 0091-2700
Source: JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.55, Iss.9, 2015-09, pp. : 1012-1023
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract